Tafinlar Trademark Details

Tafinlar was registered on Tuesday, June 14, 2011 and is currently owned by Glaxosmithkline LLC under the registration number 3976920 . This mark is alive with a status of Registered. The last case file activity for this mark occured 12 years ago on Tuesday, June 14, 2011, according to the United State Patent & Trademark Office
Word Mark Tafinlar
Status Alive Registered 700 — Registered

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Glaxo Group Limited

View all trademarks for Glaxo Group Limited
Serial Number 85094477
Registration Number 3976920
Status Date Tuesday, June 14, 2011
Filing Date Tuesday, June 14, 2011
Registration Date Tuesday, June 14, 2011
Attorney Maury M. Tepper, III
Domestic Representative Novartis Pharmaceuticals Corporation

Correspondent

Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609

Case File Statements

Goods & Services Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Sunday, August 1, 2010
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.